Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes-Reference-Cited by-同舟云学术

Mistletoe lectins I, II and III induce the production of cytokines by cultured human monocytes

Published:1996-12 Issue:1-2 Volume:109 Page:33-38
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Ribéreau-Gayon G.,Dumont S.,Muller C.,Jung M.-L.,Poindron P.,Anton R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. Immunaktive Wirkung von Mistellektin-1 in Abhängigkeit von der Dosierung;Beuth;Arzneim.-Forsch./Drug Res.,1994

2. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins;Büssing;Cancer Lett.,1996

3. Identity of the N-terminal sequences of the three mistletoe (Viscum album L.) lectins: homology with ricin-like plant toxins and single-chain ribosome-inhibiting proteins;Dietrich;Anti-Cancer Drugs,1992

4. Improved procedures for isolation and standardization of mistletoe lectins and their subunits: lectin pattern of the European mistletoe;Eifler,1993

5. The site of action of the A-chain of mistletoe lectin I on eukaryotic ribosomes: the RNA N-glycosidase activity of the protein;Endo;FEBS Lett.,1988

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lectins in oncology and virology: Mechanisms of anticancer activity and SARS-CoV-2 inhibition;International Journal of Biological Macromolecules;2024-08

2. Plant lectin: A promising future anti-tumor drug;Biochimie;2022-11

3. European Mistletoe (Viscum album) Extract Is Cytotoxic to Canine High-Grade Astrocytoma Cells In Vitro and Has Additive Effects with Mebendazole;Veterinary Sciences;2022-01-15

4. Exposure to Dengue Envelope Protein Domain III Induces Nlrp3 Inflammasome-Dependent Endothelial Dysfunction and Hemorrhage in Mice;Frontiers in Immunology;2021-02-25

5. Thermosensitive liposomes for triggered release of cytotoxic proteins;European Journal of Pharmaceutics and Biopharmaceutics;2018-11